Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03114319
Title Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | ESP | CAN

Facility Status City State Zip Country Details
H Lee Moffitt Cancer Center and Research Institute . Tampa Florida 33612 United States Details
Dana Farber Cancer Center Boston Massachusetts 02215 United States Details
Memorial Sloane Ketterin Cancer Ctr Main Centre New York New York 10065 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37221 United States Details
Novartis Investigative Site Toronto Ontario M5G 1Z5 Canada Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Kobe-shi 650-0017 Japan Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Rotterdam Zuid Holland 3015 GD Netherlands Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field